Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
---|---|
Contact name | Lada Beara-Lasic |
Contact phone | 919-541-8979 |
Contact email | Lada.Beara-Lasic@va.gov |
PI name | John Lieske |
Owner | Lada Beara Lasic |
Institution | Mayo Clinic |